PT Galih Cipta Wisesa is an Indonesian company with nearly two decades of expertise spanning pharmaceutical distribution, filtration engineering, endotoxin testing, and disinfection solutions. Since its establishment in 2007, the company has continuously expanded its capabilities to serve the pharmaceutical, food and beverage, and healthcare industries.
A key area of the company's expertise lies in endotoxin testing, having pioneered the introduction of TAL reagents in Indonesia in 2015 for use in sterile injection products within the pharmaceutical industry. TAL, derived from the Asian horseshoe crab (Tachypleus tridentatus), has been widely adopted by leading pharmaceutical companies in Indonesia as a reliable alternative to conventional LAL-based endotoxin test agents.
PT Galih Cipta Wisesa has also built strong expertise in sanitation, environmental monitoring, and filtration, offering specialized products and engineering solutions tailored to the stringent requirements of the pharmaceutical and food and beverage sectors. As a manufacturer of disinfectants and hand sanitizers, the company further extends its technical capabilities to the production and delivery of comprehensive disinfection services for healthcare facilities, educational institutions, offices, and residential properties.
This expertise was demonstrated on a national scale in 2020, when PT Galih Cipta Wisesa contributed to Indonesia's COVID-19 response by supplying disinfection machines, disinfectants, and disinfection services to key institutions including Artha Graha Peduli, Galang Island COVID Hospital, and the BIN Mobile PCR Lab.